Association study of schizophrenia with polymorphisms at six candidate genes

103Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Clinical studies have shown that there is a genetic contribution to the pathogenesis of schizophrenia. The molecular mechanisms of effective antipsychotic drugs and recent advances in neural development suggest that several dopamine receptor, serotonin receptor and neurotrophic factor genes might be involved in the disorder. In this study, we assessed the associations between schizophrenia and polymorphisms in the D2 and D3 dopamine receptor (DRD2, DRD3), the serotonin 2A receptor (5HTR2A), the brain-derived neurotrophic factor (BDNF), the ciliary neurotrophic factor (CNTF) and the neurotrophin-3 (NT-3) genes. Our results suggest that the polymorphisms at the DRD3, 5HTR2A, CNTF and BDNF gene loci are unlikely to make our sample more genetically susceptible to schizophrenia. However, we found significant differences in microsatellite allele frequencies between schizophrenic and control groups for DRD2 in the whole sample and for DRD2 and NT-3 only in women. Therefore, clinical differences in the presentation of schizophrenia between gender might be related to genetic factors. © 2001 Elsevier Science B.V.

Cite

CITATION STYLE

APA

Virgos, C., Martorell, L., Valero, J., Figuera, L., Civeira, F., Joven, J., … Vilella, E. (2001). Association study of schizophrenia with polymorphisms at six candidate genes. Schizophrenia Research, 49(1–2), 65–71. https://doi.org/10.1016/S0920-9964(00)00106-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free